Diabetes, characterized by abnormal blood glucose levels, is a chronic disorder leading to several complications like cardiovascular disease, blindness, kidney disease, amputations etc. People with diabetes die at rates two to four times higher than those who do not have it.
Insulin injections happens to be the only popular diagnostic approach for diabetes. Researchers are trying hard to develop more alternative treatments for this life-threatening disease. They want to synthesize something which is safe, effective as well as less expensive.
Most recently in a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases at the Joslin Diabetes Center in Boston it has been found that anti-inflammatory drug salsalate administered to arthritis patients can lower blood sugar levels significantly.
Presently NIDDK wants to fund a follow-up study. It will be a major clinical trial by the name Targeting Inflammation with Salsalate in Type 2 Diabetes, or TINSAL-T2D. The objective behind this study is to determine if this non-steroidal drug used to relieve mild to moderate pain, fever, arthritis and other musculoskeletal conditions will be well tolerated by diabetic patients and effective over a longer period.
Though salsalate is cheap and easily available yet it has several side effects to stain its collars. It elevates risk of heart attacks, strokes, ulcers and stomach bleeding.
However, NIDDK’s senior adviser for diabetes translational research, Myrlene Staten believes that the outcome of this study has the potential for significant public health benefit.
Filed under Diabetes, Diabetes Drug, Diabetes awareenss | Tags: amputations, arthritis, blindness, cardiovascular disease, complications, Diabetes, drug salsalate, kidney disease, musculoskeletal conditions, type 2 diabetes | Comment Below